5 studies on PNC-27 curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
Bottom line: TitrateLab indexes 77 published PNC-27 COA source records from third-party laboratories, covering 43 publicly attributable vendor identities. Across 64 records with positive numeric purity, the arithmetic mean is 99.26%. 0 records report zero purity; these remain in the record count and are excluded from the positive-purity mean. 0 positive purity results are below 90%; 4 records report measured amount more than 10% below the label. The latest recorded test date is 2026-09-30. TitrateLab did not perform these laboratory tests. Source records are not unique batches, and vendor identity does not establish manufacturing role, product safety or overall quality.
As of 2026-10-18, vendor-blind retail asking-price averages for the US delivery market, calculated from the same in-stock exact-strength cells as the Peptide Price Index. Shipping is excluded.
| Strength | Average / vial | Observed range / vial | Average / mg | Coverage |
|---|---|---|---|---|
| 5 mg | $12.50 | $12.50–$12.50 | $2.50 | 1 source · 1 offer |
| 30 mg | $35.50 | $35.50–$35.50 | $1.18 | 1 source · 1 offer |
Asking prices are not manufacturing cost and do not establish product equivalence, quality, safety, or legality. View full price methodology →
All published source records, including absent and zero purity. Matching uses a case-insensitive exact peptide token. No deduplication in the headline; vendor rankings deduplicate eligible certificates separately. The COA archive can use normalized compound names and a different measurement or duplicate policy; totals from these populations need not match.
Latest recorded test: 2026-09-30. Aggregate calculated: 2026-10-18T04:27:45.236114+00:00. Calculation time is not a laboratory observation date.
Within that total, 17 source records have unresolved vendor identity. They remain in corpus-level lab evidence and are excluded from named-vendor rankings.
Eligible vendors have at least 2 deduplicated certificates and 2 classifiable identity observations. Rank uses the 95% lower confidence bound on clean identity results; mean positive purity and certificate count break ties. Missing measurements are not passes. Exact-zero/not-detected and explicit wrong-compound markers count once per adverse certificate. This describes submitted-sample evidence, not every product or shipment, and is not an endorsement.
| Rank | Vendor | Deduplicated certificates | Avg positive purity | Identity adverse results | |
|---|---|---|---|---|---|
| #1 | 6 | 99.27% | 0 of 6 (0.0%) 0 0% / not detected · 0 wrong compound | Reveal with Pro → | |
| #2 | 3 | 99.73% | 0 of 3 (0.0%) 0 0% / not detected · 0 wrong compound | Reveal with Pro → | |
| #3 | 3 | 99.62% | 0 of 2 (0.0%) 0 0% / not detected · 0 wrong compound · 1 unclassified | Reveal with Pro → |
Vendor identities are included with Pro. Record counts and lab measurements remain visible.
Recent source records: #116606 (98.71%) · #115597 (98.25%) · #112439 · #110282 (99.36%) · #110666 (99.04%) · #107915 (99.24%)
This study provides a proof-of-concept for a scalable and efficient method of producing complex, cell-penetrating peptides, which are often difficult to synthesize. For researchers working with peptides like **p53pAnt…
These ex vivo findings suggest PNC-27 could be a valuable therapeutic agent for ovarian cancer, a disease with high mortality despite initial chemo-responsiveness. The peptide’s effectiveness against both newly diagno…
This study provides compelling in-vitro evidence that **PNC-27** can selectively target and induce necrosis in **leukemia** cells by binding to membrane `HDM-2`. **This mechanism offers a potential pathway for develop…
This study elucidates the direct, physical mechanism by which **PNC-27** selectively kills cancer cells. For researchers and potential users, this highlights that the peptide's efficacy is based on a membranolytic act…
The potential significance of PNC-27 remains entirely theoretical without empirical data on its biological interactions. Its intricate peptide structure suggests it could potentially interact with various biological t…
Free, no account — handy when you're working with PNC-27.
Pro members save studies and unlock the full evidence breakdown and vendor lab data.
Buyer protection: Wrong or defective product? Report it within 7 days. We broker a refund or reship with the vendor.
$14 monthly or $88/year
Create an account